Global and United States Avelumab Market Report & Forecast 2024-2031

Report ID: 1869238 | Published Date: Jan 2025 | No. of Page: 72 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Avelumab Product Introduction
    1.2 Global Avelumab Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Avelumab Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Avelumab Sales in Volume for the Year 2017-2028
    1.3 United States Avelumab Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Avelumab Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Avelumab Sales in Volume for the Year 2017-2028
    1.4 Avelumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Avelumab in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Avelumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Avelumab Market Dynamics
        1.5.1 Avelumab Industry Trends
        1.5.2 Avelumab Market Drivers
        1.5.3 Avelumab Market Challenges
        1.5.4 Avelumab Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Avelumab Market Segment by Type
        2.1.1 By Usage
        2.1.2 By Specifications
    2.2 Global Avelumab Market Size by Type
        2.2.1 Global Avelumab Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Avelumab Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Avelumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Avelumab Market Size by Type
        2.3.1 United States Avelumab Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Avelumab Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Avelumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Avelumab Market Segment by Application
        3.1.1 Merkel-cell Carcinoma
        3.1.2 Non-small Cell Lung Carcinoma (NSCLC)
        3.1.3 Other
    3.2 Global Avelumab Market Size by Application
        3.2.1 Global Avelumab Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Avelumab Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Avelumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Avelumab Market Size by Application
        3.3.1 United States Avelumab Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Avelumab Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Avelumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Avelumab Competitor Landscape by Company
    4.1 Global Avelumab Market Size by Company
        4.1.1 Top Global Avelumab Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Avelumab Revenue by Manufacturer (2017-2022)
        4.1.3 Global Avelumab Sales by Manufacturer (2017-2022)
        4.1.4 Global Avelumab Price by Manufacturer (2017-2022)
    4.2 Global Avelumab Concentration Ratio (CR)
        4.2.1 Avelumab Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Avelumab in 2021
        4.2.3 Global Avelumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Avelumab Manufacturing Base Distribution, Product Type
        4.3.1 Global Avelumab Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Avelumab Product Type
        4.3.3 Date of International Manufacturers Enter into Avelumab Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Avelumab Market Size by Company
        4.5.1 Top Avelumab Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Avelumab Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Avelumab Sales by Players (2020, 2021 & 2022)
5 Global Avelumab Market Size by Region
    5.1 Global Avelumab Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Avelumab Market Size in Volume by Region (2017-2028)
        5.2.1 Global Avelumab Sales in Volume by Region: 2017-2022
        5.2.2 Global Avelumab Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Avelumab Market Size in Value by Region (2017-2028)
        5.3.1 Global Avelumab Sales in Value by Region: 2017-2022
        5.3.2 Global Avelumab Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Avelumab Market Size YoY Growth 2017-2028
        6.1.2 North America Avelumab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Avelumab Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Avelumab Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Avelumab Market Size YoY Growth 2017-2028
        6.3.2 Europe Avelumab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Avelumab Market Size YoY Growth 2017-2028
        6.4.2 Latin America Avelumab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Avelumab Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Avelumab Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Merck
        7.1.1 Merck Corporation Information
        7.1.2 Merck Description and Business Overview
        7.1.3 Merck Avelumab Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Merck Avelumab Products Offered
        7.1.5 Merck Recent Development
    7.2 Pfizer
        7.2.1 Pfizer Corporation Information
        7.2.2 Pfizer Description and Business Overview
        7.2.3 Pfizer Avelumab Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Pfizer Avelumab Products Offered
        7.2.5 Pfizer Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Avelumab Industry Chain Analysis
    8.2 Avelumab Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Avelumab Distributors
    8.3 Avelumab Production Mode & Process
    8.4 Avelumab Sales and Marketing
        8.4.1 Avelumab Sales Channels
        8.4.2 Avelumab Distributors
    8.5 Avelumab Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Avelumab CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Avelumab Market Trends
    Table 3. Avelumab Market Drivers
    Table 4. Avelumab Market Challenges
    Table 5. Avelumab Market Restraints
    Table 6. Global Avelumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Avelumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Avelumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Avelumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Avelumab Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Avelumab Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Avelumab Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Avelumab Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Avelumab Sales Share by Manufacturer, 2017-2022
    Table 15. Global Avelumab Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Avelumab Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Avelumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avelumab as of 2021)
    Table 18. Top Players of Avelumab in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Avelumab Product Type
    Table 20. Date of International Manufacturers Enter into Avelumab Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Avelumab Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Avelumab Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Avelumab Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Avelumab Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Avelumab Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Avelumab Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Avelumab Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Avelumab Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Avelumab Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Avelumab Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Avelumab Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Avelumab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Avelumab Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Avelumab Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Avelumab Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Avelumab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Avelumab Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Avelumab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Avelumab Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Avelumab Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Merck Corporation Information
    Table 43. Merck Description and Business Overview
    Table 44. Merck Avelumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Merck Avelumab Product
    Table 46. Merck Recent Development
    Table 47. Pfizer Corporation Information
    Table 48. Pfizer Description and Business Overview
    Table 49. Pfizer Avelumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Pfizer Product
    Table 51. Pfizer Recent Development
    Table 52. Key Raw Materials Lists
    Table 53. Raw Materials Key Suppliers Lists
    Table 54. Avelumab Customers List
    Table 55. Avelumab Distributors List
    Table 56. Research Programs/Design for This Report
    Table 57. Key Data Information from Secondary Sources
    Table 58. Key Data Information from Primary Sources
List of Figures
    Figure 1. Avelumab Product Picture
    Figure 2. Global Avelumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Avelumab Market Size 2017-2028 (US$ Million)
    Figure 4. Global Avelumab Sales 2017-2028 (K Pcs)
    Figure 5. United States Avelumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Avelumab Market Size 2017-2028 (US$ Million)
    Figure 7. United States Avelumab Sales 2017-2028 (K Pcs)
    Figure 8. United States Avelumab Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Avelumab Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Avelumab Report Years Considered
    Figure 11. Product Picture of Type I
    Figure 12. Product Picture of Type II
    Figure 13. Global Avelumab Market Share by Type in 2022 & 2028
    Figure 14. Global Avelumab Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Avelumab Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Avelumab Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Avelumab Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Avelumab Price by Type (2017-2028) & (USD/Pcs)
    Figure 19. United States Avelumab Market Share by Type in 2022 & 2028
    Figure 20. United States Avelumab Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Avelumab Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Avelumab Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Avelumab Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Avelumab Price by Type (2017-2028) & (USD/Pcs)
    Figure 25. Product Picture of Merkel-cell Carcinoma
    Figure 26. Product Picture of Non-small Cell Lung Carcinoma (NSCLC)
    Figure 27. Product Picture of Other
    Figure 28. Global Avelumab Market Share by Application in 2022 & 2028
    Figure 29. Global Avelumab Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Avelumab Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Avelumab Sales by Application (2017-2028) & (K Pcs)
    Figure 32. Global Avelumab Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Avelumab Price by Application (2017-2028) & (USD/Pcs)
    Figure 34. United States Avelumab Market Share by Application in 2022 & 2028
    Figure 35. United States Avelumab Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Avelumab Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Avelumab Sales by Application (2017-2028) & (K Pcs)
    Figure 38. United States Avelumab Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Avelumab Price by Application (2017-2028) & (USD/Pcs)
    Figure 40. North America Avelumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 41. North America Avelumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Avelumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 45. Europe Avelumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Avelumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 52. Asia-Pacific Avelumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Avelumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 64. Latin America Avelumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Avelumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 69. Middle East & Africa Avelumab Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Avelumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Avelumab Value Chain
    Figure 74. Avelumab Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Pfizer
Frequently Asked Questions
Avelumab report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Avelumab report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Avelumab report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Imrecoxib

Imrecoxib market is segmented by region (country), players, by Type and by Application. Players,  ... Read More

Iguratimod

Iguratimod market is segmented by region (country), players, by Type and by Application. Players, ... Read More